177 related articles for article (PubMed ID: 37174067)
21. BODY COMPOSITION IMPACT ON SURVIVAL AND TOXICITY OF TREATMENT IN PANCREATIC CANCER: CROSS-SECTIONAL PILOT STUDY.
BarrÈre APN; Piovacari SMF; UsÓn Junior PLS; Gansl RC; Pereira AZ; Hamerschlak N
Arq Gastroenterol; 2020; 57(3):278-282. PubMed ID: 33027479
[TBL] [Abstract][Full Text] [Related]
22. Body weight changes in patients undergoing chemotherapy for ovarian cancer influence progression-free and overall survival.
Mardas M; Stelmach-Mardas M; Madry R
Support Care Cancer; 2017 Mar; 25(3):795-800. PubMed ID: 27771784
[TBL] [Abstract][Full Text] [Related]
23. Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals.
Kobal B; Noventa M; Cvjeticanin B; Barbic M; Meglic L; Herzog M; Bordi G; Vitagliano A; Saccardi C; Skof E
Radiol Oncol; 2018 Sep; 52(3):307-319. PubMed ID: 30210049
[TBL] [Abstract][Full Text] [Related]
24. Computed tomography-measured body composition parameters do not influence survival in non-metastatic colorectal cancer.
Cárcamo L; Peñailillo E; Bellolio F; Miguieles R; Urrejola G; Zúñiga A; Molina ME; Larach JT
ANZ J Surg; 2021 May; 91(5):E298-E306. PubMed ID: 33682291
[TBL] [Abstract][Full Text] [Related]
25. High visceral fat-to-muscle ratio is an independent factor that predicts worse overall survival in patients with primary epithelial ovarian, fallopian tube, and peritoneal cancer.
Ham S; Choi JH; Shin SG; Lee EJ
J Ovarian Res; 2023 Jan; 16(1):19. PubMed ID: 36681847
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
Charette N; Vandeputte C; Ameye L; Bogaert CV; Krygier J; Guiot T; Deleporte A; Delaunoit T; Geboes K; Van Laethem JL; Peeters M; Demolin G; Holbrechts S; Flamen P; Paesmans M; Hendlisz A
BMC Cancer; 2019 Feb; 19(1):134. PubMed ID: 30744591
[TBL] [Abstract][Full Text] [Related]
27. Quantitative measurement of adiposity using CT images to predict the benefit of bevacizumab-based chemotherapy in epithelial ovarian cancer patients.
Wang Y; Thai T; Moore K; Ding K; McMeekin S; Liu H; Zheng B
Oncol Lett; 2016 Jul; 12(1):680-686. PubMed ID: 27347200
[TBL] [Abstract][Full Text] [Related]
28. Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy.
Dijksterhuis WPM; Pruijt MJ; van der Woude SO; Klaassen R; Kurk SA; van Oijen MGH; van Laarhoven HWM
J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):199-206. PubMed ID: 30666831
[TBL] [Abstract][Full Text] [Related]
29. Impact of CT-Determined Sarcopenia and Body Composition on Survival Outcome in Patients with Advanced-Stage High-Grade Serous Ovarian Carcinoma.
Kim SI; Kim TM; Lee M; Kim HS; Chung HH; Cho JY; Song YS
Cancers (Basel); 2020 Feb; 12(3):. PubMed ID: 32121099
[TBL] [Abstract][Full Text] [Related]
30. Skeletal Muscle Attenuation (Sarcopenia) Predicts Reduced Overall Survival in Patients with Advanced Epithelial Ovarian Cancer Undergoing Primary Debulking Surgery.
Ataseven B; Luengo TG; du Bois A; Waltering KU; Traut A; Heitz F; Alesina PF; Prader S; Meier B; Schneider S; Koch JA; Walz M; Groeben HT; Nina P; Brunkhorst V; Heikaus S; Harter P
Ann Surg Oncol; 2018 Oct; 25(11):3372-3379. PubMed ID: 30069659
[TBL] [Abstract][Full Text] [Related]
31. Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors.
Franzoi MA; Vandeputte C; Eiger D; Caparica R; Brandão M; De Angelis C; Hendlisz A; Awada A; Piccart M; de Azambuja E
Breast Cancer Res Treat; 2020 May; 181(1):199-209. PubMed ID: 32246377
[TBL] [Abstract][Full Text] [Related]
32. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
[TBL] [Abstract][Full Text] [Related]
33. Associations of muscle and adipose tissue parameters with long-term outcomes in middle and low rectal cancer: a retrospective cohort study.
Liu J; Yu X; Huang X; Lai Q; Chen J
Cancer Imaging; 2023 Jan; 23(1):5. PubMed ID: 36635737
[TBL] [Abstract][Full Text] [Related]
34. Computed Tomography-Based Body Composition Is Not Consistently Associated with Outcome in Older Patients with Colorectal Cancer.
Looijaard SMLM; Meskers CGM; Slee-Valentijn MS; Bouman DE; Wymenga ANM; Klaase JM; Maier AB
Oncologist; 2020 Mar; 25(3):e492-e501. PubMed ID: 32162794
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal Body Composition Changes Detected by [
Albano D; Dondi F; Treglia G; Tucci A; Ravanelli M; Farina D; Bertagna F
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291931
[TBL] [Abstract][Full Text] [Related]
36. CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy.
Juretzka MM; Barakat RR; Chi DS; Iasonos A; Dupont J; Abu-Rustum NR; Poynor EA; Aghajanian C; Spriggs D; Hensley ML; Sabbatini P
Gynecol Oncol; 2007 Jan; 104(1):176-80. PubMed ID: 16996584
[TBL] [Abstract][Full Text] [Related]
37. [Analysis of factors related to the prognostic benefit of neoadjuvant chemotherapy followed by interval debulking surgery in patients with advanced ovarian cancer].
Wang DF; Zhang GN; Peng CR; Shi Y; Shi XW
Zhonghua Fu Chan Ke Za Zhi; 2021 Jun; 56(6):385-392. PubMed ID: 34154313
[No Abstract] [Full Text] [Related]
38. Impact of body composition on outcomes from anti-PD1 +/- anti-CTLA-4 treatment in melanoma.
Young AC; Quach HT; Song H; Davis EJ; Moslehi JJ; Ye F; Williams GR; Johnson DB
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32747470
[TBL] [Abstract][Full Text] [Related]
39. The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma.
Gerestein CG; Eijkemans MJ; de Jong D; van der Burg ME; Dykgraaf RH; Kooi GS; Baalbergen A; Burger CW; Ansink AC
BJOG; 2009 Feb; 116(3):372-80. PubMed ID: 19187369
[TBL] [Abstract][Full Text] [Related]
40. Preoperative albumin-to-fibrinogen ratio predicts chemotherapy resistance and prognosis in patients with advanced epithelial ovarian cancer.
Yu W; Ye Z; Fang X; Jiang X; Jiang Y
J Ovarian Res; 2019 Sep; 12(1):88. PubMed ID: 31533857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]